# SpecGx LLC - Inspection Records

Source: https://www.keypedia.com/companies/specgx-llc/715bb75a-8d3a-4469-9e6d-f617c2f39c93

> Inspection records and compliance data for SpecGx LLC in Greenville, Illinois. Access full analysis and detailed observations.

---

## Details

- Name: SpecGx LLC
- FEI Number: 1419579
- City: Greenville
- State: Illinois
- Country Name: United States
- Address Line 1: 100 Louis Latzer Dr
- Zip Code: 62246
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - SpecGx LLC - 2026-02-27](https://www.keypedia.com/records/483/specgx-llc/1114cee7-20e5-4785-b5c5-5f8988e4a98c) — source: FDA, date: February 27, 2026
- [FDA Inspection 1267171 - SpecGx LLC - 2026-02-27](https://www.keypedia.com/records/fda_inspections/specgx-llc/056c8957-e9d3-4d5b-b47d-6d64b7e3c233) — source: FDA, date: February 27, 2026
- [EIR - SpecGx LLC - 2019-01-25](https://www.keypedia.com/records/eir/specgx-llc/918c07c8-0b36-4c40-9e12-af3f3fb85a8f) — source: FDA, date: January 25, 2019
- [FDA Inspection 1078654 - SpecGx LLC - 2019-01-25](https://www.keypedia.com/records/fda_inspections/specgx-llc/e32cf8ae-0cf4-475e-a6d7-3b7d931aa2e7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 25, 2019
- [483 - SpecGx LLC - 2019-01-22](https://www.keypedia.com/records/483/specgx-llc/8d977356-1fa5-4bb4-8b75-131d999af26f) — source: FDA, date: January 22, 2019
- [FDA Inspection 966214 - SpecGx LLC - 2016-03-07](https://www.keypedia.com/records/fda_inspections/specgx-llc/a5598c02-fbff-43bd-a6c0-48da7d686265) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 7, 2016
- [FDA Inspection 785017 - SpecGx LLC - 2012-06-05](https://www.keypedia.com/records/fda_inspections/specgx-llc/40625a01-0e77-4057-abaa-1e7c714712c4) — classification: No Action Indicated (NAI), source: FDA, date: June 5, 2012
- [FDA Inspection 563779 - SpecGx LLC - 2009-02-20](https://www.keypedia.com/records/fda_inspections/specgx-llc/e8fa37ab-9e64-4ad4-9dbb-b9f05a6601af) — classification: No Action Indicated (NAI), source: FDA, date: February 20, 2009

## Related Companies

- [Aptuit (Oxford) Ltd.](https://www.keypedia.com/companies/aptuit-oxford-ltd/da0ef59c-f35f-478c-a844-0d223aa34b67)
- [Apitoria Pharma Private Limited](https://www.keypedia.com/companies/apitoria-pharma-private-limited/7a543877-97f7-4c4a-8dc8-74ee9d1c0caf)
- [PolyPeptide Laboratories Private Limited](https://www.keypedia.com/companies/polypeptide-laboratories-private-limited/bf5a7a5c-b537-4d71-87ce-a45650fd2b07)
- [Cipla Ltd.](https://www.keypedia.com/companies/cipla-ltd/d90a952b-3052-4e33-9969-5db3f2bbae82)
- [Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC](https://www.keypedia.com/companies/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/0de9118f-18ec-45b8-b757-44f97c13c29c)
- [Shilpa Pharma Lifesciences Limited](https://www.keypedia.com/companies/shilpa-pharma-lifesciences-limited/4f617c67-eea7-483d-b9c7-b1dd31aabcff)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/3aa20920-7f85-4cd2-806b-a3cfb4548be8)
- [Lonza AG](https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70)
- [MedImmune U.K. Limited](https://www.keypedia.com/companies/medimmune-uk-limited/fbddd1ed-5a0c-4c65-a48e-bb2af79482ed)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/e097960f-98b1-47f2-877c-d588005879b6)

## Related Officers

- [Kara L. Roden](https://www.keypedia.com/people/kara-l-roden/72d96288-086a-4be4-a024-0aaf89948eb8)
- [company_representative](https://www.keypedia.com/people/eric-j-frazer/29b05a58-febd-4560-acb7-9c4782b58cb9)
- [company_representative](https://www.keypedia.com/people/glenn-dothager/2c766dcb-2590-4ae2-850f-9e72022bd201)
- [Tyler M. Peterson](https://www.keypedia.com/people/tyler-m-peterson/207310ee-260c-4618-a515-9895a56e2ede)